Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

17.07 -0.74 (-4.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 560,450
Open 17.60
Bid (Size) 17.07 (1)
Ask (Size) 17.20 (3)
Prev. Close 17.81
Today's Range 16.98 - 18.15
52wk Range 16.55 - 50.77
Shares Outstanding 41,969,994
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
The 7 Best Meme Stocks to Buy Now: September 2023
Consider these seven past and present faves of the Reddit set to be the best meme stocks to buy this month. 
Via InvestorPlace

Performance

YTD
-38.51%
-38.51%
1 Month
-12.51%
-12.51%
3 Month
-28.88%
-28.88%
6 Month
-27.24%
-27.24%
1 Year
-62.23%
-62.23%

More News

Read More
Jim Cramer Says No To This Fintech Titan With Declining Margins: 'I Think It's A Value Trap'
Via Benzinga
Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
Why Cassava Sciences Stock Is Trading Down Today
Via Benzinga
Why Shares of Cassava Sciences Are Dropping Wednesday
Via The Motley Fool
Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
From Cassava Sciences, Inc.
Via GlobeNewswire
Snowflake (SNOW) Stock Is Sliding Despite AI Hopes
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Splunk (SPLK) Stock the Next AI Giant?
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
From Cassava Sciences, Inc.
Via GlobeNewswire
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
Via InvestorPlace
7 Biotech Stocks to Sell in July
Via InvestorPlace
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
Via Benzinga
Stock Market Round-Up: Rivian Rides High, Meta Platforms Makes Moves, And Tesla Ticks Up
Via Benzinga
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow, S&P 500 Move Lower On Renewed Fed Fatigue
Via Talk Markets
Promising Alzheimer's Treatment: Cassava Sciences' Simufilam Slows Cognitive Decline by 38% in Clinical Study
Via Benzinga
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease
From Cassava Sciences, Inc.
Via GlobeNewswire
New Research Shows Simufilam Suppresses Overactive mTOR
From Cassava Sciences, Inc.
Via GlobeNewswire
New Publication Highlights Basic Science Supporting Simufilam
From Cassava Sciences, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.